Arcutis Biotherapeutics
ARQT
ARQT
143 hedge funds and large institutions have $797M invested in Arcutis Biotherapeutics in 2023 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 68 increasing their positions, 32 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
143
Holders Change
+2
Holders Change %
+1.42%
% of All Funds
2.29%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
22
Increased
68
Reduced
32
Closed
20
Calls
$3.99M
Puts
$1.13M
Net Calls
+$2.86M
Net Calls Change
-$8.25M
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ECM
151
ExodusPoint Capital Management
New York
| – | -$977K | -65,995 | Closed |
|
152
Squarepoint
New York
| – | -$536K | -36,227 | Closed |
|
|
SSA
153
Schonfeld Strategic Advisors
New York
| – | -$416K | -28,100 | Closed |
|
154
Russell Investments Group
London,
United Kingdom
| – | -$236K | -15,972 | Closed |
|
|
QT
155
Quantbot Technologies
New York
| – | -$215K | -14,500 | Closed |
|
156
Nisa Investment Advisors
St. Louis,
Missouri
| – | -$206K | -13,900 | Closed |
|
|
AC
157
AXQ Capital
Jersey City,
New Jersey
| – | -$203K | -13,739 | Closed |
|
|
XT
158
XTX Topco
George Town,
Cayman Islands
| – | -$181K | -12,222 | Closed |
|
|
DTL
159
Dynamic Technology Lab
Singapore
| – | -$156K | -10,521 | Closed |
|
160
ProShare Advisors
Bethesda,
Maryland
| – | -$154K | -10,379 | Closed |
|
161
Nomura Holdings
Tokyo,
Japan
| – | -$9K | -585 | Closed |
|
162
US Bancorp
Minneapolis,
Minnesota
| – | -$7.1K | -480 | Closed |
|